Abstract: A capsule endoscope 3 is inserted into a subject and transmits a capsule ID, which is received by an RF receiving unit 11 of a receiving apparatus 2. A capsule ID detecting circuit 19 detects the capsule ID. A control unit C recognizes a type of the capsule endoscope 3 based on the detected capsule ID, and changes over a threshold of received field strength of a receiving antenna. Thus, a content of processing for the capsule endoscope 3 is changed over, and a selection controller C1 selects a receiving antenna for an image receiving period from receiving antennas A1 to An.

Abstract: The present invention is intended to be able to ensure detecting whether an open-circuit occurs to a feeder within short time with simple configuration. A receiving apparatus 2 according to the present invention receives image information transmitted from a capsule endoscope 3 through a coaxial cable and a receiving antenna selected and switched to from among coaxial cables 9a to 9d connected to receiving antennas 8a to 8d, respectively by a changeover switch 20. The receiving apparatus 2 includes a changeover switch 22, an open-circuit detecting circuit 23, and a control unit 26. The changeover switch 22 branches the coaxial cables 9a to 9d near the changeover switch 20, and selects and switches to one of the branched coaxial cables.

Abstract: Each of detecting circuits 36a, 36d, 36f, and 36h detects a key signal such as a horizontal synchronization signal, a vertical synchronization signal, a capsule ID, a WB coefficient, and error information, i.e., a key signal superposed on RF signals received by an RF receiving unit 33. Each of determining units 36b, 36c, 36e, 36g, and 36i determines whether an image is valid or invalid based on the result of detection. A recording deciding unit 36k decides whether to record the image information in a storage unit 35 or not based on the result of determination. Thus, a receiving apparatus 3 can stop recording the image information received when a trouble occurs, thereby preventing defective images from mixing into the recorded image information, and preventing a recorded image size from becoming large, whereby necessary images can be recorded within a predetermined examination time.

Abstract: A network relay system includes a plurality of internal network relay devices. The network relay system learns multiple pieces of route information to an external network, creates a plurality of allocation route tables designed to allocate the learnt multiple pieces of route information to the internal network relay devices. The network relay system then generates address space information showing a correlation of IP address ranges on an IP address space between the allocation route tables and respectively registers the allocation route tables, along with the generated address space information, in the internal network relay devices. Each of the internal network relay devices transfers a data frame, based on the address space information and the allocation route table registered in the self-device.

Abstract: A capsule endoscope includes a string that has one end attached to a main body of the capsule endoscope and another end secured at a predetermined position, and a wind-up unit that is provided in the main body of the capsule endoscope to bring out and wind up the string.

Abstract: As a compound having a potent oral activity and a long-lasting cysLT1/cysLT2 receptor antagonistic activity, the compound of the formula (I): which exhibits potent antagonistic activity against the cysLT1/cysLT2 receptor, and have long-lasting effects even in case of oral administration, and therefore is useful as an oral agent for preventing and/or treating a variety of diseases, for example, respiratory disease (for example, asthma (bronchial asthma, etc.), chronic obstructive pulmonary disease (COPD), pulmonary emphysema, chronic bronchitis, pneumonia (interstitial pneumonia, etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), apnea syndrome, allergic rhinitis, sinusitis (acute sinusitis, chronic sinusitis, etc.), pulmonary fibrosis, coughing (chronic coughing, etc.), and the like) was developed.

Abstract: When a network apparatus of this invention receives an IEEE 802.3ad link application control packet from a subscriber line with a VPWS function, it processes the packet in a control unit without relaying the packet by VPWS. More specifically, the network apparatus receives an IEEE802.3ad link aggregation control packet along with receiving an IEEE802.3x flow control packet. The network apparatus transmits a link aggregation control packet. The network apparatus also relays other layer 2 control protocol packets without receiving them, and does not transmit the other layer 2 control protocol packets.

Abstract: A receiving apparatus that can prevent beforehand that a portable recording medium is erroneously ejected during examination, and can prevent body cavity image data from being lost and the portable recording medium from being damaged is provided. When an ejection operation of the portable recording medium is detected (step S103: Yes) during a recording operation (step S101: Yes), a warning unit is operated before the portable recording medium is ejected to give a warning to a user so as not to perform the ejection operation (step S105). Accordingly, the portable recording medium can be prevented beforehand from being ejected during the recording operation, thereby preventing body cavity image data from being lost and the portable recording medium from being damaged.

Abstract: A portable simplified image display apparatus and a receiving system are provided, which can sensuously know the state of received strength of radio signals transmitted from a body-insertable apparatus, in either case of before examination or during examination. A viewer (7) includes a detector that detects received strength of a radio signal transmitted from a capsule endoscope (2) and a notifying unit that notifies the detected state of received strength in a display pattern such as a picture display of a capsule (41). Therefore, in either case of before examination or during examination, the state of received strength of radio signals transmitted from the capsule endoscope (2) can be sensuously known according to the notification result of the state of received strength. If it is during examination, supplementary observation can be performed based on an excellent received image by searching a site having strong received strength, thereby enabling contribution to satisfactory examination.

Abstract: A condition for determining that an examination by a capsule endoscope 3 (body insertable device) completes is set in advance. When a predetermined time period has passed since the examination starts, and when received electric-field strength of receiving antennas A1 to An detected during a predetermined time period is not higher than a predetermined value, the examination is determined to have been completed. An examination completion determining unit C1 determines whether the condition is satisfied or not. According to the result of determination, a notification controller C2 makes a notifying unit 15 notify that the examination completes, and a power supply controller C3 stop power supply to a radio unit 2a. Thus, unnecessary power consumption is prevented and the completion of the examination by the body insertable device is recognized.

Abstract: An object is to provide a cell phone capable of achieving improvement in efficiency of communication and improvement in user's operability on the occasion of providing location information. A cell phone 10 has a data transmitter 101 for transmitting user data to a content delivery server 30, using a user channel, a location request part 102 for transmitting request information to request calculation of location information about the cell phone 10, to a GPS server 40 in accordance with the transmission of the user data, using a control channel, a location acquiring part 103 for acquiring the location information calculated based on the request information by the GPS server 40, using the control channel, and a location transmitter 105 for transmitting the location information to the content delivery server 30, using the control channel.

Abstract: To realize a receiving system that can excellently receive radio signals before and after a body insertable device, which is a radio signal source, is inserted into a subject, the receiving system has a first receiving antenna (1), a second receiving antenna (2), and a receiving apparatus (3). The first receiving antenna (1) is used when the body insertable device is outside the subject. The second receiving antenna (2) is used when the body insertable device is inserted into the subject. The receiving apparatus (3) performs a receiving processing on radio signals received through the first receiving antenna (1) or the second receiving antenna (2).

Abstract: A receiving apparatus includes a receiving unit that receives an image signal, identification information on a transmitting apparatus, and color adjusting information that are radio transmitted from the transmitting apparatus; a lock controller that locks the color adjusting information when the receiving unit receives at least one of consecutively repeated identical color adjusting information and consecutively repeated identical identification information during a predetermined period or when the receiving unit most often receives at least one of the identical color adjusting information or the identical identification information during the predetermined period; and an image processing unit that performs image processing on the received image signal based on the locked color adjusting information.

Abstract: The present invention relates to a compound of formula (I) (wherein all symbols have the same meanings as described hereinbefore). The compound antagonizes cysLT2 and therefore, it is useful as an agent for the prevention and/or treatment of respiratory diseases such as bronchial asthma, bronchial asthma, chronic obstructive pulmonary disease, pneumonectasia, chronic bronchitis, pneumonia (e.g. interstitial pneumonitis etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), and the like, or as an expectorant or antitussives.

Abstract: The present invention relates to a compound of formula (I) (wherein all symbols have the same meanings as described hereinbefore). The compound antagonizes cysLT2 and therefore, it is useful as an agent for the prevention and/or treatment of respiratory diseases such as bronchial asthma, bronchial asthma, chronic obstructive pulmonary disease, pneumonectasia, chronic bronchitis, pneumonia (e.g. interstitial pneumonitis etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), and the like, or as an expectorant or antitussives.

Abstract: As a compound having a potent oral activity and a long-lasting cysLT1/cysLT2 receptor antagonistic activity, the compound of the formula (I): which exhibits potent antagonistic activity against the cysLT1/cysLT2 receptor, and have long-lasting effects even in case of oral administration, and therefore is useful as an oral agent for preventing and/or treating a variety of diseases, for example, respiratory disease (for example, asthma (bronchial asthma, etc.), chronic obstructive pulmonary disease (COPD), pulmonary emphysema, chronic bronchitis, pneumonia (interstitial pneumonia, etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), apnea syndrome, allergic rhinitis, sinusitis (acute sinusitis, chronic sinusitis, etc.), pulmonary fibrosis, coughing (chronic coughing, etc.), and the like) was developed.

Abstract: When a network apparatus of this invention receives an IEEE 802.3ad link application control packet from a subscriber line with a VPWS function, it processes the packet in a control unit without relaying the packet by VPWS. More specifically, the network apparatus receives an IEEE802.3ad link aggregation control packet along with receiving an IEEE802.3x flow control packet. The network apparatus transmits a link aggregation control packet. The network apparatus also relays other layer 2 control protocol packets without receiving them, and does not transmit the other layer 2 control protocol packets.

Abstract: The network relay device of the invention carries out data transmission to and from an opposite device to relay data in a network. The network relay device includes: multiple ports connecting with corresponding multiple ports of the opposite device via multiple links; and a link aggregation control module that aggregates the multiple links to establish a link aggregation, which is regarded as one logic link, and carries out transmission of a control frame signal including a synchronization bit, as well as data transmission, at each port via the link aggregation. In response to detection of occurrence of a trouble in at least one of the aggregated multiple links, the link aggregation control module causes a port that connects with a normal link without the trouble among the multiple ports to stop the data transmission and send the control frame signal including the synchronization bit set equal to a first value.

Abstract: The present invention relates to a compound represented by the formula (I), wherein all symbols are as defined in the description, a salt thereof, a solvate thereof, or a prodrug thereof, which has a leukotriene receptor antagonistic activity which is expected to be more effective than those of the leukotriene receptor antagonists currently used in clinical trials. Therefore, it is useful as an agent for the prevention and/or treatment of a leukotriene-mediated disease such as a respiratory diseases such as bronchial asthma, chronic obstructive pulmonary disease, pulmonary emphysema, chronic bronchitis, pneumonia (e.g. interstitial pneumonia etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), or the like, or as an expectorant or an antiitussive.

Abstract: When a network apparatus of this invention receives an IEEE 802.3ad link application control packet from a subscriber line with a VPWS function, it processes the packet in a control unit without relaying the packet by VPWS. More specifically, the network apparatus receives an IEEE802.3ad link aggregation control packet along with receiving an IEEE802.3x flow control packet. The network apparatus transmits a link aggregation control packet. The network apparatus also relays other layer 2 control protocol packets without receiving them, and does not transmit the other layer 2 control protocol packets.